Kiniksa Pharmaceuticals International, plc (KNSA)
Market Closed
16 Oct, 08:00 PM
NASDAQ (NGS) NASDAQ (NGS) Primary $
78. 59
-1.35
-1.6888%
$
6.08B Market Cap
84.4 P/E Ratio
- Div Yield
524,800 Volume
-0.16 Eps
$ 79.94
Previous Close 
Want to track KNSA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Kiniksa Pharmaceuticals International, plc Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 William Staveacre Aster Capital Management (DIFC) Ltd. | 21,398 | $1.37M | $1.72M | $350,820.21 | 25.64% |
| BCG BIT Capital GmbH BIT Capital GmbH | 5,138 | $211,942.5 | $415,227.47 | $203,284.97 | 95.92% |
| EG Ethan Gilbert Rialto Wealth Management LLC | 2 | $128 | $159.88 | $31.88 | 24.91% |
| GFM GF Fund Management Co. Ltd. GF Fund Management Co. Ltd. | 973 | $23,341.36 | $75,349.12 | $52,007.76 | 222.81% |
| JCB John Ciaran Burns Universal-Beteiligungs- und Servicegesellschaft mbH | 99,852 | $4.28M | $7.98M | $3.71M | 86.69% |
 Kilter Group LLC Kilter Group LLC | 61 | $1,688 | $4,876.34 | $3,188.34 | 188.88% |
2026 © Marketlog. All Rights Reserved.
